Kinetic Characterization of Factor Xa Binding Using a Quenched Fluorescent Substrate Based on the Reactive Site of Factor Xa Inhibitor from Bauhinia ungulata Seeds

Author(s): M. L.V. Oliva, S. A. Andrade, M. A. Juliano, R. C. Sallai, R. J. Torquato, M. U. Sampaio, V. J. Pott, C. A.M. Sampaio.

Journal Name: Current Medicinal Chemistry

Volume 10 , Issue 13 , 2003

Submit Manuscript
Submit Proposal

Abstract:

The specific Kunitz Bauhinia ungulata factor Xa inhibitor (BuXI) and the Bauhinia variegata trypsin inhibitor (BvTI) blocked the activity of trypsin, chymotrypsin, plasmin, plasma kallikrein and factor XIIa, and factor Xa inhibition was achieved only by BuXI (Ki 14 nM). BuXI and BvTI are highly homologous (70%). The major differences are the methionine residues at BuXI reactive site, which are involved in the inhibition, since the oxidized protein no longer inhibits factor Xa but maintains the trypsin inhibition. Quenched fluorescent substrates based on the reactive site sequence of the inhibitors were synthesized and the kinetic parameters of the hydrolysis were determined using factor Xa and trypsin. The catalytic efficiency kcat / Km 4.3 x 10-7 M-1sec-1 for Abz-VMIAALPRTMFIQ-EDDnp (lead peptide) hydrolysis by factor Xa was 10-4 - fold higher than that of Boc-Ile-Glu-Gly-Arg-AMC, widely used as factor Xa substrate. Lengthening of the substrate changed its susceptibility to factor Xa hydrolysis. Both methionine residues in the substrate influence the binding to factor Xa. Serine replacement of threonine (P1) decreases the catalytic efficiency by four orders of magnitude. Factor Xa did not hydrolyze the substrate containing the reactive site sequence of BvTI, that inhibits trypsin inhibitor but not factor Xa. Abz-VMIAALPRTMFIQ-EDDnp prolonged both the prothrombin time and the activated partial thromboplastin time, and the other modified substrates used in this experiment altered blood-clotting assays.

Keywords: blood clotting enzymes, factor xa, fluorescent substrate, plant kunitz inhibitor, peptide substrate, plasma kallikrein inhibitor, serine proteinase inhibitor, primary sequence

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 10
ISSUE: 13
Year: 2003
Page: [1085 - 1093]
Pages: 9
DOI: 10.2174/0929867033457548
Price: $58

Article Metrics

PDF: 7